This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

June 16 - 17, 2021

Gail Bormel, RPh, JD
Associate Director for Compounding at FDA

Agenda Sessions

  • Breakout Discussion: Impact of the Memorandum Of Understanding (MOU)

  • FDA KEYNOTE ADDRESS ● Expectations for the Future